Research

A study recently published in *The Lancet Regional Health – Europe* calls into question the benefits of immunoadsorption—a specialized form of blood purification—for post-COVID syndrome. While the autoantibodies, which are thought to be a possible cause of the condition, can be removed from the blood, this does not improve the symptoms of those affected. The […]

Highly endowed research prize goes to Harvard scientist Mathias Lichterfeld on the proposal of Ruperto Carola In order to further strengthen Heidelberg University as an internationally recognized location of infection research, Prof. Dr Mathias Lichterfeld has been selected for an Alexander von Humboldt Professorship endowed with 7.8 million euros. Leading international academics are granted this […]

Funding from the European Research Council for projects at Ruperto Carola and the Central Institute of Mental Health Prof. Dr Fred Hamprecht from the Interdisciplinary Center for Scientific Computing of Heidelberg University is receiving valuable funding from the European Research Council (ERC), an ERC Advanced Grant, which will support a project in the field of […]

Colorectal cancer is generally considered a disease of older adults. However, a new analysis of German cancer registries shows that the number of new colorectal cancer cases among younger adults has risen slightly over the past two decades. Those most affected are people between the ages of 20 and 39. The findings are based on […]

Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses Paris, June 23, 2026. The European Commission has approved Cenrifki (tolebrutinib) for the treatment of secondary progressive multiple sclerosis (SPMS) without relapses in the last two years. This follows the positive opinion by the European Medicines Agency’s Committee […]

The health status of children admitted to the hospital after a mild traumatic brain injury must be closely monitored. The two project partners have developed a robot that can assist staff with routine health checks on these patients. Full text in German below. Fraunhofer IPA und LMU Klinikum präsentieren robotisches Assistenzsystem für die Kindermedizin Pressemitteilung […]

Gelatin is a versatile natural material. To tailor its properties specifically to the requirements of various applications in medicine, diagnostics, and cosmetics, the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB has developed a toolbox for chemical functionalization. With the help of automated processes, the modifications can now be scaled under defined conditions, and reproducible […]

Researchers at the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology and University Hospital Dresden present the next stage of medical AI in a new study published in Nature. Researchers from the Heidelberg Faculty of Medicine at Heidelberg University and Heidelberg University Hospital were also involved. The team led […]

‍ ZURICH, SWITZERLAND – June 10, 2026 — VERAXA Biotech AG, an emerging leader in designing novel cancer therapies, today announced that its previously announced business combination (“Business Combination”) with Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), a special purpose acquisition company sponsored by Cantor Fitzgerald & Co., Voyager Acquisition Sponsor Holdco LLC, and Odeon Capital Group LLC, was […]